CTLT logo

Catalent (CTLT) Company Overview

Profile

Full Name:

Catalent, Inc.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

United States

IPO:

July 31, 2014

Indexes:

Not included

Website:

http://www.catalent.com

Description:

Catalent, Inc. - a provider of advanced technologies for the development and production of drug delivery solutions; protein, cell and gene therapy biological products, as well as consumer health products. The company was founded in 2007, headquartered in Somerset, New Jersey. Production assets are represented by 53 facilities on 4 continents: 22 facilities are located in the USA. The company annually produces more than 7,000 different products in several categories: branded drugs, generic drugs, biological products for protein, cell and gene therapy, over-the-counter drugs, as well as veterinary products, medical devices and diagnostic products.

Key Details

Price

-

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$4.38 B(+2.77% YoY)

Annual EPS

-$5.76(-305.63% YoY)

PE Ratio

-

Annual ROE

-25.39%

Annual Debt To Equity

1.36

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 7, 2025

Recent annual earnings:

Aug 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Sep 24, 24 Baird
Neutral
Sep 3, 24 William Blair
Market Perform
Jul 11, 24 RBC Capital
Sector Perform
Jun 28, 24 Barclays
Equal-Weight
Apr 4, 24 Stephens & Co.
Equal-Weight
Feb 20, 24 RBC Capital
Sector Perform
Feb 6, 24 UBS
Neutral
Feb 6, 24 Stephens & Co.
Equal-Weight
Feb 6, 24 RBC Capital
Sector Perform
Jan 25, 24 Barclays
Equal-Weight

Screeners with CTLT included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

-
CTLT price value is unknown

Price All-time High

$142.35
CTLT price is currently at an all-time high

Price Analysts Target

$63.50
CTLT price is currently equal to the consensus analysts' forecast

Price Most Recent Change

-
CTLT price change on Jan 1, 1 is unknown

Price YTD Change

-
CTLT price ytd change is unknown

Price 3-Year Change

-
CTLT price 3-year change is unknown

Market cap

Market Cap

-
CTLT market capitalization value is unknown

Market Cap 3-Year Change

-
CTLT market capitalization 3-year change is unknown

Market Cap All-time High

$24.32 B
CTLT market capitalization is currently at an all-time high

Market Cap Sector Rank

-
CTLT market capitalization is unknown

Technical

Beta

-
CTLT beta value is unknown

200-day SMA

-
CTLT SMA 200 is unknown

14-day RSI

-
CTLT 14-day relative strength index value is unknown

30-day Relative Volume

-
CTLT 30-day relative volume value is unknown

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$4.38 B
CTLT annual revenue is $4.38 billion

Annual Revenue Analysts Estimate

$4.63 B
CTLT annual revenue is currently -5.42% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+2.77%
CTLT annual revenue is up +2.77% year-on-year

Annual Revenue Sector Rank

-
CTLT annual revenue is unknown

Profit

Annual Gross Profit

$953.00 M
CTLT annual gross profit is $953.00 million

Annual Gross Margin

21.75%
CTLT annual gross profit margin is 21.75%

Annual Operating Profit

-$62.00 M
CTLT annual operating income is -$62.00 million

Annual Operating Margin

-1.42%
CTLT annual operating profit margin is -1.42%

Annual Net Income

-$1.04 B
CTLT annual net profit is -$1.04 billion

Annual Net Margin

-23.81%
CTLT annual net profit margin is -23.81%

EPS

Annual EPS

-$5.76
CTLT annual earnings per share is -$5.76

Annual EPS Analysts Estimate

$1.17
CTLT annual earnings per share is currently -592.73% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-305.63%
CTLT annual earnings per share is down -305.63% year-on-year

Annual EPS Sector Rank

-
CTLT annual earnings per share is unknown

ROA & ROE

Annual ROA

-10.16%
CTLT annual return on assets is -10.16%

Annual ROE

-25.39%
CTLT annual return on equity is -25.39%

EBIT & EBITDA

Annual EBIT

-$773.00 M
CTLT annual earnings before interest & taxes is -$773.00 million

Annual EBITDA

-$773.00 M
CTLT annual EBITDA is -$773.00 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CTLT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CTLT price to earnings ratio is unknown

PB Ratio

PB Ratio

-
CTLT price to book ratio value is unknown

PB Ratio Sector Rank

-
CTLT price to book ratio is unknown

PS Ratio

PS Ratio

-
CTLT price to sales ratio value is unknown

PS Ratio Sector Rank

-
CTLT price to sales ratio is unknown

Enterprise value

Enterprise Value

-
CTLT enterprise value value is unknown

Enterprise Value Sector Rank

-
CTLT enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
CTLT EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
CTLT EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.52
CTLT annual current ratio is 2.52

Annual Quick Ratio

1.93
CTLT annual quick ratio is 1.93

Leverage

Annual Debt To Equity

1.36
CTLT annual debt to equity ratio is 1.36

Annual Interest Coverage Ratio

-3.04
CTLT annual interest coverage ratio is -3.04

Risk & Stability

Piotroski F-Score

5
CTLT piotroski f-score is 5

Altman Z-Score

-
CTLT altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$9.75 B
CTLT annual total assets is $9.75 billion

Annual Non Current Assets

$7.16 B
CTLT annual long term assets is $7.16 billion

Annual Current Assets

$2.60 B
CTLT annual total current assets is $2.60 billion

Annual Cash & Cash Equivalents

$289.00 M
CTLT annual cash & cash equivalents is $289.00 million

Equity

Annual Book Value

$3.60 B
CTLT annual book value is $3.60 billion

Annual Working Capital

$1.57 B
CTLT annual working capital is $1.57 billion

Liabilities

Annual Total Liabilities

$6.15 B
CTLT annual total liabilities is $6.15 billion

Annual Total Long Term Liabilities

$5.12 B
CTLT annual total long term liabilities is $5.12 billion

Annual Current Liabilities

$1.03 B
CTLT annual total current liabilities is $1.03 billion

Annual Accounts Payable

$361.00 M
CTLT annual accounts payable is $361.00 million

Debt

Annual Total Debt

$4.92 B
CTLT annual total debt is $4.92 billion

Annual Total Debt 1-Year Change

+1.19%
CTLT annual total debt is up +1.19% year-on-year

Annual Long Term Debt

$4.86 B
CTLT annual long term debt is $4.86 billion

Annual Short Term Debt

$61.00 M
CTLT annual short term debt is $61.00 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$4.44 B
CTLT annual total expenses is $4.44 billion

Annual Operating Expenses

$1.01 B
CTLT annual total operating expenses is $1.01 billion

Annual Cost Of Goods Sold

$3.43 B
CTLT annual cost of goods sold is $3.43 billion

Annual SGA

$935.00 M
CTLT annual SGA is $935.00 million

Annual D&A

$489.00 M
CTLT annual depreciation & amortization is $489.00 million

Annual Interest Expense

$254.00 M
CTLT annual interest expense is $254.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$268.00 M
CTLT annual cash flow from operations is $268.00 million

Annual CFO 1-Year Change

+5.51%
CTLT annual cash flow from operations is up +5.51% year-on-year

Annual CFI

-$327.00 M
CTLT annual cash flow from investing activities is -$327.00 million

Annual CFI 1-Year Change

+65.76%
CTLT annual cash flow from investing activities is up +65.76% year-on-year

Annual CFF

$74.00 M
CTLT annual cash flow from financing activities is $74.00 million

Annual CFF 1-Year Change

-85.8%
CTLT annual cash flow from financing activities is down -85.8% year-on-year

Free CashFlow

Annual FCF

-$59.00 M
CTLT annual free cash flow is -$59.00 million

Annual FCF 1-Year Change

+81.68%
CTLT annual free cash flow is up +81.68% year-on-year

CAPEX

Annual CAPEX

$327.00 M
CTLT annual capital expenditures is $327.00 million

Annual CAPEX 1-Year Change

-43.23%
CTLT annual capital expenditures is down -43.23% year-on-year

Institutional Ownership

Similar stocks

FAQ

  • What is the ticker symbol for Catalent?
  • Does Catalent pay dividends?
  • What sector is Catalent in?
  • What industry is Catalent in?
  • What country is Catalent based in?
  • When did Catalent go public?
  • Is Catalent in the S&P 500?
  • Is Catalent in the NASDAQ 100?
  • Is Catalent in the Dow Jones?
  • When was Catalent's last earnings report?
  • When does Catalent report earnings?
  • Should I buy Catalent stock now?

What is the ticker symbol for Catalent?

The ticker symbol for Catalent is NYSE:CTLT

Does Catalent pay dividends?

No, Catalent does not pay dividends

What sector is Catalent in?

Catalent is in the Healthcare sector

What industry is Catalent in?

Catalent is in the Drug Manufacturers - Specialty & Generic industry

What country is Catalent based in?

Catalent is headquartered in United States

When did Catalent go public?

Catalent's initial public offering (IPO) was on July 31, 2014

Is Catalent in the S&P 500?

No, Catalent is not included in the S&P 500 index

Is Catalent in the NASDAQ 100?

No, Catalent is not included in the NASDAQ 100 index

Is Catalent in the Dow Jones?

No, Catalent is not included in the Dow Jones index

When was Catalent's last earnings report?

Catalent's most recent earnings report was on Feb 7, 2025

When does Catalent report earnings?

The date for Catalent's next earnings report has not been announced yet

Should I buy Catalent stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions